A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

Making a 75-milligram vial available alongside the two current options of 200 milligrams and 500 milligrams could save ...

An estimated $133 million to $336 million worth of lecanemab may be discarded every year. Adding a 75-mg vial could save ...

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Researchers are investigating whether diabetes and eye disease drugs could also be used to treat or even prevent dementia.

Researchers are investigating whether drugs currently used for diabetes and eye diseases could help to prevent or treat ...

On Monday, Eli Lilly And Co (NYSE:LLY) announced plans to boost its presence in the U.K., following a collaboration with the ...

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown ...

Alzheimer's disease, a devastating neurodegenerative condition that affects millions of people worldwide, may have found a ...

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...